Bexarotene-induced hypothyroidism: Bexarotene stimulates the peripheral metabolism of thyroid hormones

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 7, 2007, Pages 2496-2499

  Smit, Johannes W A ^a   Stokkel, Marcel P M ^a   Pereira, Alberto M ^a   Romijn, Johannes A ^a   Visser, Theo J ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BEXAROTENE; LIOTHYRONINE; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROID HORMONE; THYROTROPIN; THYROXINE; THYROXINE DERIVATIVE;

ADULT; AGED; ARTICLE; BIODEGRADATION; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; INTERVENTION STUDY; LEUKOPENIA; LIOTHYRONINE BLOOD LEVEL; LUNG METASTASIS; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THYROID CARCINOMA; THYROID HORMONE METABOLISM; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION;

EID: 34447132935     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2822     Document Type: Article

References (20)

1. Stadler R, Kremer A 2006 Therapeutic advances in cutaneous T-cell lymphoma (CTCL): from retinoids to rexinoids. Semin Oncol 33:S7-S10
2. Liu YY, Stokkel MP, Pereira AM, Corssmit EP, Morreau HA, Romijn JA, Smit JW 2006 Bexarotene increases uptake of radioiodide in metastases of differentiated thyroid carcinoma. Eur J Endocrinol 154:525-531
3. Shulman AI, Mangelsdorf DJ 2005 Retinoid x receptor heterodimers in the metabolic syndrome. N Engl J Med 353:604-615
4. Sherman SI, Gopal J, Haugen BR, Chiu AC, Whaley K, Nowlakha P, Duvic M 1999 Central hypothyroidism associated with retinoid X receptor-selective ligands. N Engl J Med 340:1075-1079
5. Sharma V, Hays WR, Wood WM, Pugazhenthi U, St.Germain DL, Bianco AC, Krezel W, Chambon P, Haugen BR 2006 Effects of rexinoids on thyrotrope function and the hypothalamic-pituitary-thyroid axis. Endocrinology 147:1438-1451
6. Liu S, Ogilvie KM, Klausing K, Lawson MA, Jolley D, Li D, Bilakovics J, Pascual B, Hein N, Urcan M, Leibowitz MD 2002 Mechanism of selective retinoid X receptor agonist-induced hypothyroidism in the rat. Endocrinology 143:2880-2885
7. Golden WM, Weber KB, Hernandez TL, Sherman SI, Woodmansee WW, Haugen BR 2007 Single-dose rexinoid rapidly and specifically suppresses serum thyrotropin in normal subjects. J Clin Endocrinol Metab 92:124-130
8. Macchia PE, Jiang P, Yuan YD, Chandarardna RA, Weiss RE, Chassande O, Samarut J, Refetoff S, Burant CF 2002 RXR receptor agonist suppression of thyroid function: central effects in the absence of thyroid hormone receptor. Am J Physiol Endocrinol Metab 283:E326-E331
9. Howell SR, Shirley MA, Ulm EH 1998 Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes. Drug Metab Dispos 26:234-239
10. Visser TJ, Docter R, Hennemann G 1977 Radioimmunoassay of reverse triiodothyronine. J Endocrinol 73:395-396
11. Eelkman Rooda SJ, Kaptein E, van Loon MA, Visser TJ 1988 Development of a radioimmunoassay for triiodothyronine sulfate. J Immunoassay 9:125-134
12. Wu SY, Huang WS, Polk D, Florsheim WH, Green WL, Fisher DA 1992 Identification of thyroxine-sulfate (T4S) in human serum and amniotic fluid by a novel T4S radioimmunoassay. Thyroid 2:101-105
13. Breen JJ, Hickok NJ, Gurr JA 1997 The rat TSHβ gene contains distinct response elements for regulation by retinoids and thyroid hormone. Mol Cell Endocrinol 131:137-146
14. Haugen BR, Brown NS, Wood WM, Gordon DF, Ridgway EC 1997 The thyrotrope-restricted isoform of the retinoid-X receptor-γ1 mediates 9-cis-retinoic acid suppression of thyrotropin-β promoter activity. Mol Endocrinol 11:481-489
15. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38-89
16. Esfandiari A, Gagelin C, Gavaret JM, Pavelka S, Lennon AM, Pierre M, Courtin F 1994 Induction of type III-deiodinase activity in astroglial cells by retinoids. Glia 11:255-261
17. Kester MH, Kuiper GG, Versteeg R, Visser TJ 2006 Regulation of type III iodothyronine deiodinase expression in human cell lines. Endocrinology 147:5845-5854
18. de Sandro V, Catinot R, Kriszt W, Cordier A, Richert L 1992 Male rat hepatic UDP-glucuronosyltransferase activity toward thyroxine. Activation and induction properties - relation with thyroxine plasma disappearance rate. Biochem Pharmacol 43:1563-1569
19. Eelkman Rooda SJ, Kaptein E, Visser TJ 1989 Serum triiodothyronine sulfate in man measured by radioimmunoassay. J Clin Endocrinol Metab 69:552-556
20. Smit JW, Eustatia-Rutten CF, Corssmit EP, Pereira AM, Frolich M, Bleeker GB, Holman ER, van der Wall EE, Romijn JA, Bax JJ 2005 Reversible diastolic dysfunction after long-term exogenous subclinical hyperthyroidism: a randomized, placebo-controlled study. J Clin Endocrinol Metab 90:6041-6047